Send to

Choose Destination
Oncotarget. 2018 Oct 26;9(84):35470-35471. doi: 10.18632/oncotarget.26245. eCollection 2018 Oct 26.

BET inhibitors: Betting on improved outcomes in uterine serous carcinoma.

Author information

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.


GS-5829; GS-626510; bromodomain and extraterminal motif proteins; endometrial cancer; uterine serous carcinoma

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center